1071TiP Phase I study of the investigational CD228 x 4-1BB costimulatory antibody anticalin bispecific SGN-BB228 (PF-08046049) in advanced melanoma and other solid tumors
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1129